Effectively raised awareness of the value of Chimeric Antigen Receptor T-cell therapy by securing interest on mainstream platforms such as CNN Indonesia, Bloomberg, Straits Times, Life!, CNA938 and MoneyFM 89.3 in a span of 3 months.
Currently implementing a new campaign for conversations on late-stage breast cancer. Our scope will include media relations, influencer engagement, as well as panel discussions featuring experts and patients.
